The Board of DIrectors at their meeting held today, 21/May/2026, inter alia, approved the following: 1) Migration of equity shares to main Board of BSE and NSE 2) Making Application ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries Ltd's Board of Directors approved migrating its equity shares from the BSE SME Platform to the Main Board of BSE Limited. The company also approved making an application for listing its shares on the Main Board of NSE. Both actions are subject to shareholder approval, which will be sought via a postal ballot. The company has appointed NSDL for e-voting facilities and Mr. Vishal Manseta as scrutinizer for the postal ballot process. The board meeting was held on May 21, 2026, and lasted from 9:00 AM to 9:40 AM.
Migration to the Main Board signals the company's growth and compliance with higher regulatory standards, which could attract broader institutional investor interest and improve stock liquidity. Shareholders should expect to receive a postal ballot notice for their approval on this migration.